Correlations between indicators of interleukin-10 and interleukin-6 in patients with periodic disease


Cite item

Full Text

Abstract

Aim. Determination of the concentration of interleukin-10 (IL-10) and interleukin-6 (IL-6) in serum of patients with periodic disease (PD) before and after treatment with colchicin, as well as the identification of correlation between the indicators of these parameters. Materials and methods. We examined 188 patients with PD (89 men, 99 women) aged from 12 to 69 years, as well as 44 patients with rheumatoid arthritis (RA) as a comparison group and 41 healthy people of the control group. Patients were divided into groups: 1 - PD colchicinotherapy patients with seizures without amyloidosis that do not respond to treatment maximum dose of colchicine 2.0 mg/day; 2nd-PD patients without amyloidosis, not responding to treatment 1.5 mg/day colchicine; 3rd - PD patients that responds to certain doses of colchicine (0.5 to 2.0 mg/day); 4th - PD patients without amyloidosis who did not receive treatment; 5-I of the healthy persons of the control group; 6-I - RA patients. The concentration of IL-10 in blood serum was determined by enzyme immunoassay ELISA, and IL-6 - immunochemiluminescent method. For statistical processing the computer program SPSS is used. The results were considered statistically significant at the level of reliability p<0.05. The results and discussion. The results of the studies showed the same nature of changes in IL-10 production in different groups of patients. Statistically significant positive correlation of elevated serum concentrations of IL-6 and IL-10 (p<0.05) was found in patients with PD of all groups, as well as in patients with RA. Conclusion. In patients with PD (both colchicin-resistant and colchicin-sensitive) increased serum concentration of IL-10 was accompanied by an increased level of IL-6 in serum. Changes in the level of IL-10 in PD have a certain prognostic and pathogenetic significance and lead to the development of "persistent, sluggish" inflammatory process in the extracurricular period of PD in both colchicin-resistant and other groups of patients with PD.

About the authors

Z T Jndoyan

Yerevan State Medical University

Email: jndoyanzinaida@rambler.ru
зав. каф. пропедевтики внутренних болезней, зав. клиникой терапии университетской больницы “Гераци” №1 Armenia

A Yu Bablumyan

Yerevan State Medical University

доцент каф. урологии и андрологии, директор университетской больницы “Гераци” №1 Armenia

K V Ginosyan

Yerevan State Medical University

доцент каф. пропедевтики внутренних болезней, врач-ревматолог университетской больницы “Гераци” №1 Armenia

S V Shekoyan

Yerevan State Medical University

доцент каф. кардиологии, врач-кардиолог университетской больницы “Гераци” №1 Armenia

References

  1. Beuter B. Innet immunity: an overview. Mol Immunol. 2004; 40: 499-513. doi: 10.1016/j.molimm.2003.10.005
  2. Aridogan B, Yildirim M, Baysal V et al. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-Gamma in Behçet's Disease. J Dermatol. 2003 Aug; 30(8):602-7. doi: 10.1111/j.1346-8138.2003.tb00442.x
  3. Sky Ng T.N, Britton G, Hill E et al. Regulation of Adaptive Immunity; the Role of Interleukin-10. Front Immunol. 2013;4:129. doi: 10.3389/ fimmu.2013.00129
  4. Simsek I, Pay S, Pekel A et al. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int. 2007; 27(9): 807-811. doi: 10.1007/s00296-006-0301-6
  5. Saito K, Ait-Goughoulte M, Truscott S et al. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production. J Virol. 2008; 82(7): 3320-3328. doi: 10.1128/jvi.02547-07
  6. Roque S, Correia-Neves M, Mesquita A et al. Interleukin-10: AKeyCytokineinDepression? Cardiovasc Psychiatry and Neurology. 2009. doi: 10.1155/2009/187894
  7. Кузьмина Н., Федоров Е., Мовсисян Г., Салугина С. Аутовоспалительные заболевания у детей - современный взгляд на проблему. Научно - практ ревматол. 2009; 1: 63-75. doi: 10.14412/1995-4484-2009-144
  8. Cazeneuve C, Hovannesyan Z, Genevieve D, Hayrapetyan H, Papin S et al. (2003) Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum. 48: 2324-2331. doi: 10.1002/art.11102
  9. Sait B, Bulent T, Tuzun A et al. Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheum. 2004; 23(4): 333-337. doi: 10.1007/s10067-004-0925-4
  10. Ozen S, Roux-Lombard P et al. Profile of cytokines, growth factors and chemokines during attacкs of FMF. 5thInternat. Congress of FMF and Autoinfl Dis. 2008: 192. doi: 10.1186/1546-0096-6-S1-P207
  11. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002;4(suppl.13): 233-242. doi: 10.1186/ar565
  12. Kimura A, Naka T, Kishimoto T. IL-6-dependent and independent pathways in the development of interleukin-17-producing T helper cells. Proc Nat Acad Sci. USA, 2007; 104(29): 12099-12104. doi: 10.1073/pnas.0705268104
  13. Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010; 40: 1830-1835. doi: 10.1002/eji.201040391
  14. Богданова М.В., Рамеев В.В., Козловская Л.В., Федоров Е.С., Салугина С.О. Сывороточный кальгранулин С - высокочувствительный показатель аутовоспаления у больных семейными периодическими лихорадками. Терапевтический архив. 2016;88(6):58-64. doi: 10.17116/terarkh201688658-64

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies